Top Markets
Coin of the day
AlzeCure Pharma AB AlzeCure Pharma AB

AlzeCure Pharma AB

ALZCUR
Clasificación en acciones #22112
AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops... AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involved in the development of drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its products pipeline includes ACD856 for the treatment of Alzheimer’s disease, sleep disorders, depression, traumatic brain injuries, and Parkinson’s disease, which is in phase I clinical trial; ACD857, ACD679, and ACD680 that are in preclinical trial for the treatment of Alzheimer’s disease; ACD440, a TRPV1 antagonist that has completed phase I clinical trial for neuropathic pain indications; and ACD137, negative allosteric modulator (NAM) of TrkA receptors for osteoarthritic pain indications. The company was founded in 2012 and is based in Huddinge, Sweden.
Precio por acción
$0.71707249
Última sincronización: 2026-08-21
Capitalización bursátil
$94.14M
Cambio (1 día)
-3.31%
Cambio (1 año)
76.82%
País
SE
Comercio AlzeCure Pharma AB (ALZCUR)

Categoría

Historial de desdoblamientos de acciones de AlzeCure Pharma AB (ALZCUR)
La acción AlzeCure Pharma AB (símbolo: ALZCUR) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 23, 2026.
Una acción ALZCUR comprada antes de Aug 23, 2026 equivaldría hoy a 0 acciones ALZCUR.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH